BridgeBio Pharma (BBIO) Capital Expenditures (2018 - 2026)
BridgeBio Pharma's Capital Expenditures came in at $290,000 for Q3 2026, down 38.3% from $470,000 a year earlier and down 34.5% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Capital Expenditures (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, BridgeBio Pharma reported Capital Expenditures of $835,000, down 24.8% year-over-year; for FY2025, it came in at $1.1 million, up 17.6% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $933,000 in FY2024 (-28.6%), $1.31 million in FY2023 (-72.9%), $4.82 million in FY2022 (-69.3%) and $15.7 million in FY2021 (+108.8%).
- The five-year range for quarterly Capital Expenditures is $12,000 (Q1 2023) to $2.54 million (Q4 2021).
- Year-over-year, Capital Expenditures increased in 1 of the last five quarters, with growth averaging 12.1%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q3 2025 (growth of 243.1%), and the weakest in Q1 2023 (a decline of 98.6%).
- Business Quant data shows BBIO's Capital Expenditures at $443,000 (Q2 2026), $69,000 (Q1 2026) and $33,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | 290,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 290,000.00 |
| Jun 30, 2026 | 443,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | 470,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 695,000.00 |
| Dec 31, 2023 | 435,000.00 |
| Sep 30, 2023 | 431,000.00 |
| Jun 30, 2023 | 428,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 801,000.00 |
| Sep 30, 2022 | 759,000.00 |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 859,000.00 |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | 6.78 Mn |
API Access
BridgeBio Pharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();